Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT04479930 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Effects of an mHealth Web-Based Platform (HappyAir) on Adherence to a Maintenance Program After Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease

Start date: December 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Objective: This study aimed to assess the effects of an integrated care plan based on an mHealth web-based platform (HappyAir) on adherence to a 1-year maintenance program applied after pulmonary rehabilitation in COPD patients. Methods: COPD patients from three hospitals were randomized to a control group or an intervention group (HappyAir group). Patients from both groups received an 8-week program of pulmonary rehabilitation and educational sessions about their illness. After completion of the process, only the HappyAir group completed an integrated care plan for 10 months, supervised by an mHealth system and therapeutic educator. The control group only underwent the scheduled check-ups. Adherence to the program was rated using a respiratory physiotherapy adherence self-report (CAP FISIO) questionnaire. Other variables analyzed were adherence to physical activity (Morisky-Green Test), quality of life (Chronic Obstructive Pulmonary Disease Assessment Test, St. George's Respiratory Questionnaire, and EuroQOL-5D), exercise capacity (6-Minute Walk Test), and lung function.

NCT ID: NCT04479540 Completed - Pneumonia, Viral Clinical Trials

Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease

COVIDEP
Start date: May 26, 2020
Phase: N/A
Study type: Interventional

The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is complicated by pneumonia (15 to 20% of cases) requiring hospitalization with oxygen therapy. Almost 20 to 25% of hospitalized patients require intensive care and resuscitation; half die. The main cause of death is acute respiratory distress syndrome (ARDS). However, some deaths have been linked to pulmonary embolism (PE). Recognition of PE is important because there is specific treatment to limit its own mortality. The identification of biological parameters of hemostasis predictive of thromboembolic disease is crucial in these patients. To evaluate the frequency of PE in the patients having to be hospitalized is to practice of a systematic thoracic angiography scanner in the patients having no contra-indication for its realization, as well as during hospitalization in patients deteriorating without any other obvious cause. The thromboembolic events and disturbances of the coagulation system described in patients with SARS-CoV-2 pneumonitis suggest that this viral infection is associated with an increase in the activation of coagulation contributing to the occurrence of thrombosis and especially from PE.

NCT ID: NCT04478253 Recruiting - Pneumopathy Clinical Trials

Virtual Reality Hypnosis for Thoracic Drain Insertion

VeRHiTY
Start date: May 23, 2020
Phase: N/A
Study type: Interventional

The main objective of this study is to evaluate, in vigilant resuscitation patients, the effect of the use of HYPNO VR on the pain felt during the insertion of a thoracic drain.

NCT ID: NCT04474717 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis (Clinical and Biochemical Study)

Start date: November 15, 2020
Phase: N/A
Study type: Interventional

one-centered, open, non-randomized, controlled clinical trial will focus on a comprehensive study of the clinical, functional and molecular biochemical characteristics of the natural course of COPD in combination with peripheral atherosclerosis

NCT ID: NCT04467333 Recruiting - Clinical trials for Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Giessen Pulmonary Hypertension in Lung Cancer Registry

PHLHR
Start date: June 29, 2020
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

NCT ID: NCT04463134 Not yet recruiting - Clinical Outcomes Clinical Trials

An Observational Study on Patients With NTM Pulmonary Disease

Start date: August 1, 2020
Phase:
Study type: Observational

Non-tuberculous mycobacterial (NTM) infection is becoming more and more common, especially causing pulmonary diseases in those elderly or the immunocompromised. The diagnosis, treatment and monitoring of NTM pulmonary disease(NTMPD) are not updated and real life management if also challenging.

NCT ID: NCT04462289 Enrolling by invitation - Clinical trials for Pulmonary Disease, Chronic Obstructive

Electronic Proactive Outreach for Smokers With COPD

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases, with 90% of cases directly attributable to smoking. Unfortunately, many patients continue to smoke and have an urgent need to quit. Proactive tobacco treatment programs identify patients outside of a routine clinical appointment and engage them in making a supported quit attempt. Most previous research of proactive tobacco treatment has used telephone outreach, which can be resource intensive. Electronic methods (texting, secure messaging) may be effective while requiring fewer resources. In this study, a previously tested telephone outreach intervention will be adapted for electronic delivery, with content tailored to smokers with COPD. First, information will be gathered from smokers with COPD and the medical staff who care for them to adapt the program for electronic delivery. Then, the program will be pilot-tested. Smokers with COPD will be randomly assigned to either usual medical care or the outreach intervention, with goals to increase participation in smoking cessation programs, quit attempts, and successful cessation.

NCT ID: NCT04460391 Not yet recruiting - Pulmonary Disease Clinical Trials

Influence of Early Standing Training on ICU Patients

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Influence of early standing training on ICU patients

NCT ID: NCT04459156 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Fiber Metabolism in Chronic Obstructive Pulmonary Disease

Start date: June 23, 2020
Phase: N/A
Study type: Interventional

The impact of fiber intake on short chain fatty acid (SCFA) metabolism has not been studied in subjects suffering from COPD. The purpose of this study is to compare changes in SCFA metabolism after inulin vs. placebo intake in COPD patients to healthy matched controls. This protocol is an extension of a recent study about whole-body SCFA production rates in COPD patients. The investigators hypothesize that a short-term fiber supplementation increases SCFA production in COPD patients.

NCT ID: NCT04459143 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD) and Advance Directives

DIABPCO
Start date: May 16, 2019
Phase:
Study type: Observational

The aim of this study is to evaluate if the participation of COPD patients to a workshop on advance directives increases the number of patients who write them.